HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Briggs, M. C. Articles by Hunt, J. A. Search for Related Content PubMed PubMed Citation Articles by Briggs, M. C. Articles by Hunt, J. A.

Active Scatter Factor (HGF/SF) in Proliferative Vitreoretinal Disease

¹ From the St. Paul’s Eye Unit, Royal Liverpool University Hospital; and the ² Unit of Ophthalmology, Department of Medicine, and ³ Department of Clinical Engineering, University of Liverpool, United Kingdom.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
PURPOSE. Hepatocyte growth factor/scatter factor (HGF/SF) possesses mitogenic, motogenic, and morphogenic properties and has recently been implicated in various retinal diseases. The role of HGF/SF in proliferative vitreoretinal disease was investigated.

METHODS. Sections of epiretinal membranes were stained immunohistochemically for cytokeratins, to identify HRPE cells, and for HGF/SF receptor (c-Met). Cultured HRPE cells were stained for c-Met and investigated for shape change in response to HGF/SF, by using image analysis. The dose–response relationship for HRPE cells to HGF/SF was investigated by a cell migration assay and the specificity of this response evaluated by a neutralization experiment. Subretinal fluid (SRF) and vitreous from patients with retinal detachment and proliferative vitreoretinopathy (PVR) plus vitreous from eyes obtained after death, eyes with macular hole, and eyes with proliferative diabetic retinopathy (PDR) were investigated for the presence of HGF/SF using an enzyme-linked immunosorbent assay (ELISA). HGF/SF activity was measured using an MDCK cell scatter assay.

RESULTS. HRPE cells in epiretinal membranes and in culture expressed c-Met. Cultured HRPE cells responded to HGF/SF by an epithelial-to-mesenchymal shape change and by cell migration, a response that increased with increasing concentrations of HGF/SF. This response was reduced in the presence of neutralizing antibody. There was evidence of HGF/SF in increasing concentrations in more severe PVR and in PDR when measured by ELISA, and, conversely, there was evidence of correspondingly decreasing HGF/SF activity when measured by MDCK cell scatter assay in these diseases.

CONCLUSIONS. HGF/SF is present in normal and pathologic vitreous. HRPE cells respond by shape change and cell migration to HGF/SF. Concentrations of HGF/SF increase in proliferative vitreoretinal disease and increase in turn with increased severity of the disease, but HGF/SF bioactivity decreases (consistent with activator depletion). These findings are consistent with the hypothesis that HGF/SF may play a role in the HRPE mesenchymal transformation that typifies PVR.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
In healthy eyes, retinal pigment epithelial (RPE) cells form a polarized monolayer adjacent to the photoreceptors and are involved in diverse activities that are essential to retinal homeostasis and visual function.¹ In normal circumstances RPE cells are stationary and mitotically feeble. In contrast, they become activated and mobilized in proliferative vitreoretinopathy (PVR), which is the major complication of rhegmatogenous retinal detachment (RRD) surgery. Indeed, dissemination of migratory, proliferating RPE cells from their normal site on Bruch’s membrane to multiple loci on the detached neuroretina is thought to be a key pathologic event in the genesis of the complex epiretinal membranes associated with the development of PVR.^{2 3 4 5 6 7 8}

The basic pathomolecular mechanism by which the sedentary RPE cells become activated is still poorly understood, but the morphologic and functional alterations that take place have been described in detail in the experimental work of Machemer and Laqua in owl monkeys.² Migratory and proliferative RPE cells undergo a phenotypic change so that many of them resemble fibroblasts.^{2 6 9 10} The shape change associated with the fibroblastic alteration is so dramatic that it has been called metaplasia,^{2 9 10} although epithelial-to-mesenchymal transition^{6 11} may be more appropriate.

Undoubtedly the RPE cell transition is modulated by soluble growth factors and cytokines.^{5 12 13 14 15 16 17} Fibroblast growth factor (FGF), tumor necrosis factor (TNF)-, interleukin (IL)-1, IL-6, interferon (IFN)-, transforming growth factor (TGF)-ß, platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF), among others, are elevated in PVR,^{15 17} and it is known that most of these polypeptides are capable of modifying RPE behavior in numerous ways, including division, migration, matrix synthesis, enzyme production, and contraction.^{15 18} Also, successful attempts have been made to locate, by immunohistochemistry, growth factors and cytokines within the microenvironment of the epiretinal membrane.^{14 19} Although the list of growth factors and cytokines that may have a role in RPE cell activation and the development of PVR is long, there may be others with an important role that have not been investigated in detail so far.²⁰

One growth factor that may have a pivotal role in the activation of RPE cells from stationary cells to mobile and proliferating cells is hepatocyte growth factor, also known as scatter factor (HGF/SF).^{21 22 23} Typically, it is associated with increasing the motility of various types of epithelium,^{21 24} and the responsive target cells express the c-Met receptor.²⁵ The term scatter factor was coined because the polypeptide promotes the dissociation or scattering of formed colonies of cultured epithelium to the extent that a bioassay for the factor was developed based on the factor’s ability to scatter cells such as Madin–Darby canine kidney epithelial (MDCK) cells.^{21 22 23 24} It has been noted that during the scattering process, the rounded epithelioid cells invariably adopt a fibroblast or spindle shape.²⁶ A very similar phenotypic change is undertaken by RPE in the early stages of PVR,^{2 6} which can be considered to be an epithelial-to-mesenchymal transition.

In addition to motogenic and shape-altering effects, the factor is also a mitogen. It has been found to be identical with HGF, which stimulates hepatocytes, and a number of other cells, to divide,²⁷ and the two names have therefore been joined (HGF/SF), but if one name is preferred, it is usually HGF that prevails. Lacrimal gland–derived HGF/SF in tears may well modulate corneal epithelial cell proliferation, migration, and differentiation.²⁸ Inside the eye, it may be that HGF/SF is a normal constituent of aqueous humor.²⁹ HGF/SF is produced by corneal stromal keratocytes in wound healing, and the corneal epithelium is a target cell.^{30 31} Corneal epithelium expresses the c-Met receptor,³⁰ as do lens epithelial cells.³² A complication of cataract surgery is the development of postsurgical scar-like tissue where the fibroblastic cells are thought to be derived from lens epithelium. It is therefore of relevance that HGF/SF may be an important growth factor in postcataract scar tissue development.³³

Recently, evidence has been published that suggests that RPE may express the c-Met receptor.^{20 34} That being the case, HGF/SF may have a key role in the epithelial-to-mesenchymal transition of RPE cells that heralds the development of complex membranes in PVR, but obviously this can be hypothesized only if HGF/SF is present in the pathologic vitreous. The present study was undertaken to determine whether there was any HGF/SF in normal and PVR vitreous that could produce scattering of epithelium and shape changes in RPE cells. In addition we wanted to confirm whether the c-Met receptor was present on human cultured RPE (HRPE) cells and whether there were cells expressing the c-Met receptor as constituents of epiretinal membranes.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Collection of Specimens
Core vitreous was obtained from six eyes after death (9.5–22 hours) by aspiration through the pars plana with a 23-gauge needle. Pathologic specimens of vitreous were obtained during standard pars plana vitrectomy procedures for macular hole,⁵ RRD without PVR,¹⁶ RRD with grade A or B PVR,¹² RRD with grade C PVR,³² idiopathic epiretinal membrane,⁴ and proliferative diabetic retinopathy (PDR).³⁶ Specimens were obtained from the aspiration tubing before infusion began to avoid sample contamination by infusion fluid. Subretinal fluid (SRF) was collected by aspiration through a sclerotomy, with a 2-ml syringe and a Brunswick (27-gauge) needle, from eyes undergoing surgery for RRD without PVR,⁶ RRD with grade A or B PVR,¹ or RRD with Grade C PVR.¹ Specimens contaminated with blood from the choroidal plexus were excluded. The material obtained by each of these techniques was immediately transferred to a siliconized Eppendorf tube (Sigma, Poole, UK). Each tube was centrifuged at 10,000 rpm for 5 minutes and the supernatant frozen at -70° until analysis.

Specimens of epiretinal membrane were obtained at vitrectomy from 13 patients with PVR (in one of whom RRD followed local resection of choroidal melanoma), 3 with macular pucker (2 idiopathic, 1 after proton beam irradiation for malignant melanoma of the choroid), and 2 with PDR.

Cell Cultures
MDCK cells are an immortal line of transformed canine kidney epithelial cells that are particularly responsive to HGF/SF in culture.²¹ MDCK cells were obtained from Porton Down tissue culture collection (PHLS Centre for Applied Microbiology and Research, Porton Down, Salisbury, UK) and grown in Dulbecco’s minimal essential medium (DMEM) with 5 ml glutamine, 5 ml penicillin-streptomycin and 10% fetal calf serum (FCS) in 150-ml flasks (Sterilin, Stone, UK). Flasks were placed in an incubator (LEEC, Nottingham, UK) at 37°C in 5% CO₂. MRC-5 cells are a transformed line of human fetal lung fibroblasts that produce HGF/SF in culture.²¹ These cells were obtained from Porton Down and grown in 150-ml flasks in DMEM with 5 ml glutamine, 5 ml penicillin-streptomycin, and 10% FCS. To obtain conditioned medium containing HGF/SF, MRC-5 cells were grown to confluence and washed three times with phosphate-buffered saline (PBS) and serum-free medium (DMEM) added to the flasks. These flasks were incubated for 48 hours at 37°C in 5% CO₂. This medium was then removed, aliquoted into siliconized Eppendorf tubes (Sigma) and frozen at -70° until required. HRPE cells were established in culture using standard techniques.^{35 36} They were isolated from eyes with no known ophthalmic disease that were obtained up to but not exceeding 48 hours after death. The isolated cells were grown in Ham’s F10 medium supplemented with 20% FCS, 5 ml amphotericin B, and 5 ml penicillin-streptomycin and their purity confirmed by cytokeratin staining. Cells were grown in 25-cm² flasks until confluent and then passaged or frozen in dimethyl sulfoxide in liquid nitrogen. Cells between the third and eighth passages were used for all experiments.

Enzyme-Linked Immunosorbent Assay
A noncompetitive sandwich enzyme-linked immunosorbent assay (ELISA), using a monoclonal anti-HGF antibody (A3.1.2; Genentech, San Francisco, CA), was established to provide a quantitative estimate of HGF/SF levels in appropriate vitreous samples. All wells of 96-well plates were coated with 100 µl of primary antibody (A3.1.2.) at a concentration of 5 ng/ml in coating buffer. Plates were incubated at room temperature for 16 hours and washed in a solution of 20% Tween in PBS (pH 7.6), and 200 µl blocking buffer (1% bovine serum albumin [BSA] in PBS) was added. After further washing, specimens or standard concentrations (range, 0.5–100 ng/ml) of single-chain HGF (Genentech) in diluent solution (0.5% BSA in PBS) in a volume of 50 µl were added to each plate and incubated at room temperature for 2 hours. After another wash, 100 µl of secondary antibody (rabbit-raised polyclonal anti-HGF; Genentech) was added at a concentration of 1:5000 in a diluent solution. Plates were washed, 100 µl of a biotinylated amplification antibody (monoclonal anti-goat IgG; Sigma) was added at a concentration of 1:5000 in a diluent solution, and the plates were incubated for 1 hour. The plates were then washed, 100 µl avidin-horseradish peroxidase (Sigma) was added at a concentration of 1:6000 in a diluent solution, and the plates were incubated at room temperature for 1 hour. The Plates were washed and coated with 100 µl substrate solution o-phenylenediamine (Sigma) in 0.2 M citric acid titrated to pH 5 by potassium hydroxide. The reaction was stopped with 2 M sulfuric acid. Plates were read at 490 nm (model 312e plate reader; Biotek, Winooski, VT). For the purposes of this study, specimens were tested undiluted and at dilutions of 1:10 and 1:100 in diluent solution.

HGF/SF Bioassay
Two techniques were used to indirectly assess HGF/SF activity in pathologic and postmortem specimens of vitreous and SRF. The first (qualitative assay) was intended to detect whether there was activity present and the second (semiquantitative assay) to provide some measure of the activity.

The qualitative scatter assay of MDCK cell target colonies was conducted in a manner similar to that outlined in the literature.²¹ Cells were seeded at 2500 cells per well (1 ml DMEM and 10% FCS) into 24-well plates (Sterilin) and incubated at 37°C in 5% CO₂. After 24 hours, in the presence of their normal culture medium of DMEM and 10% FCS, the cells were examined, and those wells that had typical colonies of cells in the central area of the well were photographed under the x10 objective of a light microscope (Diaphot; Nikon, Melville, NY). Thereafter, 100 µl of vitreous, MRC-5–conditioned medium (MRC-5 CM), or plain DMEM was micropipetted into the wells. The central area of each well was reliably and repeatedly identified by virtue of using the darker center (which almost filled the field of view when using the x4 objective lens). After a further 24-hour incubation, the central area of the well was identified and photographed again. An assessment of the colonies of cells was made and graded as scattered, nonscattered, or equivocal. This assessment was performed in a masked fashion using photographic prints.

A semiquantitative assay was undertaken using the dilution assay first described by Stoker and Perryman.²¹ For this assay serial doubling dilutions in DMEM of the test specimen (i.e., vitreous MRC-5 CM), which served as a positive control, and DMEM, which served as a negative control, were prepared in 96-well plates. Serial dilutions of each sample and control were made (range, 1:2–1:512). The plates were then incubated at 37°C in 5% CO₂ for 24 hours. Thereafter, the plates were fixed in ethanol and stained with hematoxylin. A subjective assessment of scattering of the MDCK cells was made for each well, on the basis of their tendency to form colonies. This assessment was not masked, because the plates were marked to indicate which solution they contained and at which dilution. The lowest concentration (i.e., the highest dilution) at which scattering was observed was used to calculate the concentration of scattering activity according to the published method of Stoker and Perryman.²¹ The number of units of scattering activity per milliliter equaled the inverse of the dilution divided by the volume in each well (0.2 ml). For example, if scattering was present in a well of dilution 1:16, the scattering activity was 16 divided by 0.2 (the volume of the fluid in each well), giving a value of 80 units of scattering activity per milliliter.

No attempt to control for either pH or osmolality was made in either of the scattering bioassays. In the case of the qualitative assay, a relatively small volume of test solution (100 µl of vitreous, DMEM, or MRC-5 CM) was added to the wells that contained 1 ml DMEM and 10% FCS.

Image Analysis of Shape Change
The scattering assay of Stoker and Perryman²¹ depends on the tight cohesive colony formation associated with MDCK cells. Unfortunately, HRPE cells did not form sufficiently tight colonies in our culture conditions to allow them to be effectively evaluated by this bioassay. However, HGF/SF also produces a characteristic change in the shape of susceptible target cells.²⁶ An image analysis procedure was adapted to determine whether HGF/SF would produce a shape change in HRPE cells. MDCK cells were examined in a similar fashion to act as a positive control for the morphologic change. HRPE cells were seeded at 4000 per well in 96-well plates in Ham’s F10 and 10% FCS, glutamate, and antibiotics. In some wells, MRC-5 CM was present at a dilution of 1:4 in DMEM (positive control), and in others DMEM alone was used to act as a negative control for shape change. In addition, 12.5 ng/ml of recombinant HGF/SF (Genentech) was added to additional wells. MDCK cells were seeded at 3000 cells per well in DMEM with glutamate and antibiotics. MRC-5 CM was present in some wells. After a 24-hours incubation at 37°C in 5% CO₂, the plates were all washed with PBS, fixed in ethanol for 15 seconds, and stained with hematoxylin. Wells were screened, and randomly selected cells were analyzed (PrismView; Improvision, Coventry, UK) for cell shape. Between 301 and 568 cells were analyzed of each cell type. Cells were analyzed for roundness (4 x area/ length²), perfect circle (perfect, 1; thin and elongated, <1), and form factor (4 x x area/perimeter²; perfect circle, 1; irregular margin, <1). Statistical analysis using the Waller–Duncan K Ratio t-test was performed by the software (PrismView).

Immunohistochemistry
The epiretinal membranes were placed in acetone containing protease inhibitors (20 mM iodoacetamide and 2 mM phenylmethylsulfonyl fluoride) at -20°C overnight. After exchange in methyl benzoate, the specimens were processed into glycol methacrylate resin at +4°C (JB4; Polysciences, Warrington, PA), as previously reported.³⁷ Sections were cut at 2 µm and mounted on 2% 3-aminopropyltriethoxysilane–coated glass slides (Sigma). HRPE cells and MDCK cells for immunohistochemistry were grown on eight-chamber tissue culture slides (LabTec, Nunc; Roskilde, Denmark) to preconfluence and fixed in precooled (-20°C) methanol (5 minutes) and acetone (2 minutes).³⁸ Slides bearing tissue sections or cultured cells were rehydrated in PBS (pH 7.6), endogenous peroxide activity was blocked with 1% aqueous hydrogen peroxide, and nonspecific antibody binding was blocked with 10% normal swine serum in PBS. Incubation with primary antibody lasted 60 minutes (room temperature). The primary antibodies used in this study were polyclonal, raised in rabbits against portions of the HGF/SF c-Met receptor and characterized by Rong et al.³⁹ (a kind gift from George F. van de Woude). The polyclonal antibodies were used at a 1:200 dilution in PBS. To determine whether RPE in the membranes express c-Met, sections subsequent to those processed for c-Met detection were labeled for cytokeratins with a wide-screening rabbit antiserum (diluted 1:100 in PBS) to detect RPE cells.⁴⁰ Control preparations were processed with nonimmune rabbit serum. After washes with PBS, the preparations were incubated with biotinylated immunoglobulins F(ab)₂ fragment of sheep anti-mouse–rabbit IgG; Sigma) diluted 1:40 in PBS, washed again, and incubated with peroxidase-conjugated streptavidin (Dako) diluted 1:400 in PBS. Sites of complexes were stained brown using 3,3 diaminobenzidine tetrahydrochloride. Sections were counterstained using hematoxylin.

Chemoattraction Assay
Chemoattraction studies on cultured HRPE cells were undertaken using 48-well microchemotaxis chambers (Neuro Probe, Gaithersburg, MD), as previously described by our group.⁴¹ We studied the response to MRC-5 CM and to purified recombinant human HGF/SF (ICRF Cell Interactions Laboratory, Cambridge, UK), made up at the required range of activities in DMEM (18 ng/ml to 1.8 µg/ml). This fluid served as an alternative source of HGF/SF,²¹ and soluble fibronectin (10 µg/ml; Sigma), a known attractant for RPE cells,⁴² served as a positive control. In addition we combined MRC-5 CM with an anti-HGF/SF antibody to determine whether we could neutralize the action of HGF/SF in the conditioned medium.

The attractants were placed in 25-µl volumes in the lower wells by micropipette. A polycarbonate membrane (Nucleopore, Pleasanton, CA), perforated with 10-µm diameter pores, and a rubber gasket covered the 48 wells, and a section containing the 48 upper wells was placed on top and secured. Preconfluent cultures of HRPE cells, still in log phase of growth, were removed from their flasks with 0.25% trypsin and 0.02% EDTA. The cells were pelleted and resuspended in DMEM so that there were 40,000 RPE cells in 50 µm of solution, and this volume was pipetted into each of the upper wells. The chamber system was incubated in 95% air and 5% CO₂ at 37°C for 5 hours, after which the polycarbonate membrane was fixed in ethanol and air dried. After 30 minutes in hematoxylin, the membranes were washed in water and mounted. Counts were made of the number of cells (nuclear counts under the x100 objective of a light microscope) migrated onto the bottom surface of the stained membrane. Twenty high-power fields were evaluated from each well, representing approximately one fifteenth of the available area.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
c-Met Receptor
HRPE cells in culture showed positive staining for c-Met using both the sp460 and C28 antibodies. Epiretinal membranes removed during vitreous surgery showed positive staining for c-Met in 14 of 18 specimens (Table 1) . In 10 of the 14 the presence of HRPE cells in the sections was confirmed by positive staining with either wide-spectrum anti-cytokeratin antibody or K18 antibody, and in 6 of these specimens, c-Met clearly was observed to be codistributed with HRPE cells (Table 1 , Fig. 1 ). There was a statistically significant correlation between the presence of HRPE cells and c-Met immunoreactivity in the membranes (Table 2 ; Fisher exact test, P < 0.05).

View larger version (61K): [in this window] [in a new window]   Figure 1. Light micrographs of sections from an epiretinal membrane stained with the immunoperoxidase method for (A) cytokeratins and (B) c-Met. A layer of RPE cells is seen to express c-Met (arrows). Hematoxylin counterstain; magnification, x400.

View larger version (60K): [in this window] [in a new window]   Figure 2. Photomicrographs of cultured HRPE cells. Cells were fixed in ethanol and stained with hematoxylin. HRPE cells cultured in the (A) absence or (B) presence of HGF/SF. HRPE cells are clearly more bipolar and elongated and have more processes in (B), whereas the fan-shaped cytoplasmic ruffles characteristic of epithelioid HRPE cells are far more in evidence in (A). Magnification, x200. (C) Response of HRPE cells (cells migrating per high-power field, HPF) in a Boyden migration chamber to the following agents: MRC-5 CM containing HGF/SF, MRC-5 CM with anti-HGF/SF antibody at a concentration of 2 µg/ml (CM + HGF antibody), and increasing concentrations of recombinant HGF/SF. DMEM acted as negative control and fibronectin (10 µg/ml) as a positive control. Error bars: 1 SD. The reduction in response to MRC-5 CM with addition of anti-HGF/SF antibody was statistically significant (Mann–Whitney, P = 0.02).

Vitreous Scattering Activity
Unlike our HRPE cells, the MDCK cells in sparse culture formed compact colonies of rarely more than 50 and often fewer than 20 cells. When exposed to a source of HGF/SF for 24 hours, the colonies broke up, and the component cells scattered. The scattered MDCK cells had clear space between each cell, so that the component cells of the original colony covered an area many times larger than that occupied by the original colony. Initial investigations of specimens of vitreous from patients with PVR showed clear evidence (data not shown) that the specimens could scatter target MDCK colonies during the 24-hour test period (Fig. 3) , justifying the value of a more rigorous semiquantitative analysis.

View larger version (70K): [in this window] [in a new window]   Figure 3. Phase-contrast photomicrograph of MDCK cells in culture. (A) Colony of MDCK cells, before addition of vitreous specimen, cells formed a tight colony. (B) Same area of culture dish photographed 24 hours after the addition of vitreous specimen, showing separation of the cells. Magnification, x400.

View larger version (40K): [in this window] [in a new window]   Figure 4. Mean HGF/SF concentrations in vitreous for each diagnostic category, as measured by ELISA. Error bars: SEM. There was a statistically significant difference between the mean value for the PDR group when compared with that of the donor (postmortem), macular hole, RRD, and PVR C groups.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
It has been shown in a previous study that the HGF/SF receptor c-Met is present in epiretinal membranes associated with PVR,³⁴ but the numbers of specimens were few, and the authors were unable to determine which cell type in the membranes express the c-Met receptor. Our much larger series established that c-Met–positive cells were evident in most membranes. In addition, by using glycol methacrylate resin embedding, we had sufficiently thin sections to colocalize c-Met staining in one section, with cytokeratin (HRPE cells) staining in a subsequent section. As a result we were able to show that, much but not all, of the c-Met staining was associated with HRPE cell distribution in the membranes. Cultured HRPE cells are known to express c-Met^{34 43} but on the basis of the present results, it is likely that HRPE cells in vivo are subject to the influence of HGF/SF if present in the immediate environment.

HGF/SF is a mitogen on many cells including hepatocytes,⁴⁴ but it has only a modest proliferative effect on HRPE cells at high concentrations (500 µg/ml).^{34 43} It is a far more effective motogen. HRPE cells exhibited a powerful migratory response to MRC-5 CM and, to a lesser extent, to recombinant HGF/SF, which is in line with the results of others.^{34 43} Among the more distinctive biologic effects of HGF/SF on target cells is scattering of epithelial cells from colonies^{21 26} and alteration of the cells from an epithelioid to a fibroblastic morphology.²⁶

Colony formation was not a feature of our HRPE cells, but we were able to show, with an image analysis–based assay, that HRPE cells undergo a profound shape change when exposed to conditioned media rich in HGF/SF. We considered the loss of roundness and form factor change away from circular to be impressive, given that our wild-type cultured HRPE cell population was not synchronized, and that the original shape of the cells was therefore not very uniform. The process of sporadic cell division could have been a confounding factor. The low sensitivity of our assay was highlighted by the fact that the shape change of MDCK cells hardly registered, even though alteration was evident by eye, and MDCK cells are the gold standard for the shape-change response.²⁶ The marked shape alteration of HRPE cells seen in the present study therefore adds weight to the proposal that HGF/SF may play a key role in the epithelial-to-mesenchymal shift of HRPE cells. The shift creates epithelial cells that look and act like fibroblasts, as is found in PVR epiretinal membranes.^{2 3 4 5 6}

Those tissue culture–based experiments in which we examined the scattering and shape change effects of HGF/SF both in its recombinant form and in conditioned medium were performed in the presence of FCS, because without it the MDCK and HRPE cells would not thrive. That the wells to which only the control solution was added did not show either scattering or a shape change suggests that there was no contribution from the FCS to either of these effects.

We showed by ELISA that in normal vitreous after death there were high quantities of HGF/SF, with an average level from our samples of 2.9 ng/ml, more than 10 times higher than levels found in aqueous humor.²⁹ Our ELISA levels of HGF/SF for specimens with macular hole and RRD are reasonably comparable to those published in the recent literature.⁴⁵ However, in the only other PVR study Nishimura et al.⁴⁶ found lower quantities of the growth factor in the vitreous (3.3 ng/ml) than our values of 9 ng/ml for PVR A and B and 13 ng/ml for PVR C. The overall trend for higher levels of HGF/SF in PVR than RRD vitreous and the highest level of all in the vitreous of patients with PDR is evident in our data and is apparent in the findings in the two previous studies.^{45 46} HGF/SF is present in the blood⁴⁷ and it is therefore not surprising that in disease associated with leaky retinal vessels, such as PDR, these would be associated with particularly high levels of the growth factor.

It should be asked whether the growth factor concentration in vitreal samples is reasonably representative of what is going on at the tissue level. We attempted to do this by trying to determine whether HGF/SF levels were substantially different in two separate fluid compartments: the vitreous and the subretinal space. Unfortunately, we were unable to obtain vitreous and SRF from the same patients, but comparison showed a threefold greater average in the SRF than the vitreous when samples from groups containing RRD and the various grades of PVR, were examined. The difference did not reach statistical significance, which was probably related to the small sample size and the large variation in the SRF growth factor levels. That there was a significant trend from RRD to PVR grade C for greater amounts of vitreal HGF/SF cannot be taken to imply functional and pathobiologic consequences. It does not hold, for example, that more evidence of HGF/SF in the media means more growth factor–induced bioactivity in target cells such as HRPE cells. The growth factor may be below threshold levels for bioeffect, the receptor status of the target cells may be insufficient, and so on, but of particular relevance is whether the HGF/SF is in its active form. HGF/SF is secreted by cells as an inactive single-chained precursor,⁴⁸ and only after conversion to a heterodimer by proteolytic action does it bind strongly to the c-Met receptor and become biologically active.^{47 49 50}

The ELISA did not distinguish between inactive and active HGF/SF, but with our semiquantitative MDCK scatter assay²¹ we had the opportunity to examine HGF/SF activity, rather than amount, in the vitreous samples. Vitreous from PDR patients, not unexpectedly on the basis of the ELISA, had the greatest scattering activity, but what was surprising was that the trend for HGF/SF activity progressed downward from RRD to severe PVR—quite the opposite of the ELISA results! Clearly, further work is needed to confirm these findings and to distinguish between single chain and heterodimeric HGF/SF, and that research is going on at present.

Our working hypothesis, however, is that single-chain HGF/SF is produced continuously by local cells,⁴³ but the activator is in short supply. Thus, the proportion of heterodimeric HGF/SF, plus consequent bioactivity, goes down with the advancement of PVR, despite an overall increase in HGF/SF levels. The hypothesis fits well with the pathobiology of PVR, given that a shape change of HRPE cells and their migration (although many factors are involved in this) are considered to be early events.³ Studies of tissues other than the eye have shown that the HGF/SF activators are proteolytic and are induced in injured tissue.⁵¹ Urokinase-type plasminogen activator from macrophages⁵⁰ and a factor XII homologue from serum⁵² have been proposed as potential activators of HGF/SF elsewhere in the body. It would be useful to test this hypothesis by performing two scattering assays using one specimen of vitreous, the HGF/SF concentration of which has been measured by ELISA, before and after the addition of an exogenous activator. Unfortunately, the volume of vitreous that we routinely obtain is not adequate to perform this experiment.

Future research to identify activators in the vitreous of PDR, PVR, and RRD may shed more light on the role of HGF/SF in retinal scarring.

	Acknowledgements

 
The authors thank Lisa Heathcote and Penny Hogg for technical assistance.

	Footnotes

 
Supported by The Guide Dogs for the Blind Association, the Sir Jules Thorn Charitable Trust, and Foundation for the Prevention of Blindness.

Submitted for publication August 5, 1999; revised February 9, 2000; accepted March 15, 2000.

Commercial relationships policy: N.

Corresponding author: Michael C. Briggs, St. Paul’s Eye Unit, Royal Liverpool University Hospital, Prescot Street, Liverpool L7 8XP, UK. mcbriggs{at}aol.com

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Marmor, MF (1999) Structure function and disease of the retinal pigment epithelium Marmor, MF Wolfensberger, TJ eds. Retinal Pigment Epithelium: Function and Disease ,3-9 Oxford University Press, New York.
2. Machemer, R, Laqua, H. (1975) Pigment epithelial proliferation in retinal detachment (massive periretinal proliferation) Am J Ophthalmol 80,1-23[Medline][Order article via Infotrieve]
3. Machemer, R, Aaberg, TM, MacKenzie, F (1991) reeman H, Irvine AR, Lean JS, Michels RM An updated classification of retinal detachment with proliferative vitreoretinopathy. Am J Ophthalmol. 112,159-165[Medline][Order article via Infotrieve]
4. Anderson, DH, Stern, WH, Fisher, SK, Erickson, PA, Borgula, GA (1981) The onset of pigment epithelial proliferation after retinal detachment Invest Ophthalmol Vis Sci 21,10-16[Abstract/Free Full Text]
5. Wiedemann, P, Weller, M. (1988) The pathophysiology of proliferative vitreoretinopathy Acta Ophthalmol 189(suppl),7-15
6. Grierson, I, Hiscott, P, Hogg, P, Robey, H, Mazure, A, Larkin, G. (1994) Development, repair and regeneration of the retinal pigment epithelium Eye 8,255-262
7. Grierson, I, Hiscott, P, Sheridan, C, Tuglu, I. (1997) The pigment epithelium: friend and foe of the retina Proc R Microscopical Soc 32,161-170
8. Hiscott, P, Grierson, I (1994) Retinal detachment Garner, A Klintworth, GK eds. Pathobiology of Ocular Disease: A Dynamic Approach 2nd ,675-700 Marcel Dekker New York.
9. Mandelcorn, MS, Machemer, R, Fineberg, E, Hersch, SB (1975) Proliferation and metaplasia of intravitreal retinal pigment epithelium cell autotransplants Am J Ophthalmol 80,227-237[Medline][Order article via Infotrieve]
10. Mueller–Jensen, K, Machemer, R, Azarnia, R. (1975) Autotransplantation of retinal pigment epithelium in intravitreal diffusion chamber Am J Ophthalmol 80,530-537[Medline][Order article via Infotrieve]
11. Vidaurri-Leal, J, Hohman, R, Glaser, BM (1984) Effect of vitreous on morphological characteristics of retinal pigment epithelial cells. A new approach to the study of proliferative vitreoretinopathy Arch Ophthalmol 102,1220-1223[Abstract]
12. Campochiaro, PA, Jerdan, JA, Glaser, BM (1984) Serum contains chemoattractants for human retinal pigment epithelial cells Arch Ophthalmol 102,1830-1833[Abstract]
13. Wiedemann, P, Ryan, SJ, Novak, P, Sorgente, N. (1985) Vitreous stimulates proliferation of fibroblasts and retinal pigment epithelial cells Exp Eye Res 41,619-628[Medline][Order article via Infotrieve]
14. Leschey, KH, Hackett, SF, Singer, JH, Campochiaro, PA (1990) Growth factor responsiveness of human retinal pigment epithelial cells Invest Ophthalmol Vis Sci 3,839-846
15. Wiedemann, P. (1992) Growth factors in retinal disease: proliferative vitreoretinopathy, proliferative diabetic retinopathy, and retinal degeneration Surv Ophthalmol 36,373-384[Medline][Order article via Infotrieve]
16. Grierson, I, Mazure, A, Hogg, P, Hiscott, P, Sheridan, C, Wong, D. (1996) Non-vascular vitreoretinopathy: the cells and the cellular basis of contraction Eye 10,671-684
17. Limb, GA, Little, BC, Meager, A, et al (1991) Cytokines in proliferative vitreoretinopathy Eye 5,686-693
18. Hunt, RC, Fox, A, al Pakalnis, V (1993) Cytokines cause cultured retinal pigment epithelial cells to secrete metalloproteinases and to contract collagen gels Invest Ophthalmol Vis Sci 34,3179-3186[Abstract/Free Full Text]
19. Limb, GA, Alam, A, Earley, O, Green, W, Chignell, AH, Dumonde, DC (1994) Distribution of cytokine proteins within epiretinal membranes in proliferative vitreoretinopathy Curr Eye Res 13,791-798[Medline][Order article via Infotrieve]
20. Briggs, MC, Grierson, I, Hiscott, P, et al (1995) Scatter Factor: a possible role in proliferative vitreoretinal disease [ARVO Abstract] Invest Ophthalmol Vis Sci 36(3),S751Abstract nr 3473.
21. Stoker, M, Perryman, M. (1985) An epithelial scatter factor released by embryo fibroblasts J Cell Sci 77,209-223[Abstract]
22. Gherardi, E, Gray, J, Stoker, M, Perryman, M, Furlong, R. (1989) Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement Proc Natl Acad Sci USA 86,5844-5848[Abstract/Free Full Text]
23. Weidner, KM, Hartmann, G, Sachs, M, Birchmeier, W. (1993) Properties and functions of scatter factor/hepatocyte growth factor and its receptor c-Met Am J Respir Cell Mol Biol 8,229-237
24. Rosen, EM, Meromsky, L, Setter, E, Vinter, DW, Goldberg, ID (1990) Purified scatter factor stimulates epithelial and vascular endothelial cell migration Proc Soc Exp Biol Med 195,34-43[Abstract]
25. Bottaro, DP, Rubin, JS, Faletto, DL, et al (1991) Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product Science 251,802-804[Abstract/Free Full Text]
26. Li, Y, Joseph, A, Bhargava, MM, Rosen, EM, Nakamura, T, Goldberg, I. (1992) Effect of scatter factor and hepatocyte growth factor on motility and morphology of MDCK cells In Vitro Cell Dev Biol 28,364-368
27. Weidner, KM, Arakaki, N, Hartmann, G, et al (1991) Evidence for the identity of human scatter factor and human hepatocyte growth factor Proc Natl Acad Sci USA 88,7001-7005[Abstract/Free Full Text]
28. Li, Q, Weng, J, Mohan, RR, et al (1996) Hepatocyte growth factor and hepatocyte growth factor receptor in the lacrimal gland, tears, and cornea Invest Ophthalmol Vis Sci 37,727-739[Abstract/Free Full Text]
29. Araki–Sasaki, K, Danjo, S, Kawaguchi, S, Hosohata, J, Tano, Y. (1997) Human hepatocyte growth factor (HGF) in the aqueous humor Jpn J Ophthalmol 41,409-413[Medline][Order article via Infotrieve]
30. Wilson, SE, He, YG, Weng, J, Zieske, JD, Jester, JV, Schultz, GS (1994) Effect of epidermal growth factor, hepatocyte growth factor, and keratinocyte growth factor, on proliferation, motility and differentiation of human corneal epithelial cells Exp Eye Res 59,665-678[Medline][Order article via Infotrieve]
31. Honma, Y, Nishida, K, Sotozono, C, Kinoshita, S. (1997) Effect of transforming growth factor-beta1 and -beta2 on in vitro rabbit corneal epithelial cell proliferation promoted by epidermal growth factor, keratinocyte growth factor, or hepatocyte growth factor Exp Eye Res 65,391-396[Medline][Order article via Infotrieve]
32. Weng, J, Liang, Q, Mohan, RR, Li, Q, Wilson, SE (1997) Hepatocyte growth factor, keratinocyte growth factor, and other growth factor-receptor systems in the lens Invest Ophthalmol Vis Sci ,381543-381554
33. Wormstone, IM, Liu, CS, Rakic, JM, Marcantonio, JM, Vrensen, GF, Duncan, G. (1997) Human lens epithelial cell proliferation in a protein-free medium Invest Ophthalmol Vis Sci 38,396-404[Abstract/Free Full Text]
34. Lashkari, K, Rahimi, N, Kazlauskas, A. (1999) Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy Invest Ophthalmol Vis Sci 40,149-156[Abstract/Free Full Text]
35. Boulton, ME, Marshall, J, Mellerio, J. (1983) Retinitis pigmentosa: a preliminary report on tissue culture studies of retinal pigment epithelial cells from eight affected human eyes Exp Eye Res 37,307-313[Medline][Order article via Infotrieve]
36. McKechnie, NM, Boulton, M, Robey, HL, Savage, FJ, Grierson, I. (1988) The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo J Cell Sci 91,303-312[Abstract/Free Full Text]
37. Kanawati, C, Wong, D, Hiscott, P, Sheridan, C, McGalliard, J. (1996) "En bloc" dissection of epimacular membranes using aspiration delamination Eye 10,47-52
38. Robey, HL, Hiscott, PS, Grierson, I. (1992) Cytokeratins and retinal epithelial cell behaviour J Cell Sci 102,329-340[Abstract/Free Full Text]
39. Rong, S, Jeffers, M, Resau, JH, Tsarfaty, I, Oskarsson, M, Van de Woude, GF (1993) Met expression and sarcoma tumorigenicity Cancer Res 53,5355-5360[Abstract/Free Full Text]
40. Hiscott, P, Gray, R, Grierson, I, Gregor, Z. (1994) Cytokeratin-containing cells in proliferative diabetic retinopathy membranes Br J Ophthalmol 78,219-222[Abstract/Free Full Text]
41. Joseph, JP, Grierson, I, Hitchings, RA (1989) Chemotactic activity of aqueous humor: a cause of failure of trabeculectomies? Arch Ophthalmol 107,69-74[Abstract]
42. Campochiaro, PA, Jerdan, JA, Glaser, BM (1984) Serum contains chemoattractants for human retinal pigment epithelial cells Arch Ophthalmol 102,1830-1833
43. He, PM, He, S, Garner, JA, Ryan, SJ, Hinton, DR (1998) Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor Biochem Biophys 249,253-257
44. Matsumoto, K, Nakamura, T. (1996) Emerging multipotent aspects of hepatocyte growth factor J Biochem 119,591-600[Abstract/Free Full Text]
45. Katsura, Y, Okano, T, Noritake, M, et al (1998) Diabetes Care 21,1759-1763[Abstract]
46. Nishimura, M, Ikeda, T, Ushiyama, M, Nanbu, A, Kinoshita, S, Yoshimura, M. (1999) J Clin Endocrinol Metab. 84,659-662[Abstract/Free Full Text]
47. Zarnegar, R, Michalopoulos, G. (1989) Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes Cancer Res 49,3314-3320[Abstract/Free Full Text]
48. Miyazawa, K, Kitamura, A, Naka, D, Kitamura, N. (1991) An alternatively processed mRNA generated from human hepatocyte growth factor gene Eur J Biochem 197,15-22[Medline][Order article via Infotrieve]
49. Naka, D, Ishii, T, Yoshiyama, Y, et al (1992) Activation of hepatocyte growth factor by proteolytic conversion of a single chain form to a heterodimer J Biol Chem 267,20114-20119[Abstract/Free Full Text]
50. Naldini, L, Vigna, E, Bardelli, A, Follenzi, A, Galimi, F, Comoglio, PM (1995) Biological activation of pro-HGF (hepatocyte growth factor) by urokinase is controlled by a stoichiometric reaction J Biol Chem 270,603-611[Abstract/Free Full Text]
51. Miyazawa, K, Shimomura, T, Naka, D, Kitamura, N. (1994) Proteolytic activation of hepatocyte growth factor in response to tissue injury J Biol Chem 269,8966-8970[Abstract/Free Full Text]
52. Shimomura, T, Miyazawa, K, Komiyama, Y, et al (1995) Activation of hepatocyte growth factor by two homologous proteases, blood-coagulation factor XIIa and hepatocyte growth factor activator Eur J Biochem 229,257-261[Medline][Order article via Infotrieve]

This article has been cited by other articles:

				H.-J. Chen and Z.-Z. Ma N-Cadherin Expression in a Rat Model of Retinal Detachment and Reattachment Invest. Ophthalmol. Vis. Sci., April 1, 2007; 48(4): 1832 - 1838. [Abstract] [Full Text] [PDF]

				C. S. Alge, S. G. Priglinger, D. Kook, H. Schmid, C. Haritoglou, U. Welge-Lussen, and A. Kampik Galectin-1 Influences Migration of Retinal Pigment Epithelial Cells Invest. Ophthalmol. Vis. Sci., January 1, 2006; 47(1): 415 - 426. [Abstract] [Full Text] [PDF]

				S. C. Dieudonne, E. C. La Heij, R. Diederen, A. G. H. Kessels, A. T. A. Liem, A. Kijlstra, and F. Hendrikse High TGF-{beta}2 Levels during Primary Retinal Detachment May Protect against Proliferative Vitreoretinopathy Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4113 - 4118. [Abstract] [Full Text] [PDF]

				M. Jin, Y. Chen, S. He, S. J. Ryan, and D. R. Hinton Hepatocyte Growth Factor and its Role in the Pathogenesis of Retinal Detachment Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 323 - 329. [Abstract] [Full Text] [PDF]

				J Troger, S Sellemond, G Kieselbach, M Kralinger, E Schmid, B Teuchner, Q A Nguyen, E Schretter-Irschick, and W Gottinger Inhibitory effect of certain neuropeptides on the proliferation of human retinal pigment epithelial cells Br. J. Ophthalmol., November 1, 2003; 87(11): 1403 - 1408. [Abstract] [Full Text] [PDF]

				E. H. Van Aken, O. De Wever, L. Van Hoorde, E. Bruyneel, J.-J. De Laey, and M. M. Mareel Invasion of Retinal Pigment Epithelial Cells: N-cadherin, Hepatocyte Growth Factor, and Focal Adhesion Kinase Invest. Ophthalmol. Vis. Sci., February 1, 2003; 44(2): 463 - 472. [Abstract] [Full Text] [PDF]

				P. A. Hogg, I. Grierson, and P. Hiscott Direct Comparison of the Migration of Three Cell Types Involved in Epiretinal Membrane Formation Invest. Ophthalmol. Vis. Sci., August 1, 2002; 43(8): 2749 - 2757. [Abstract] [Full Text] [PDF]

				Y. Ikuno and A. Kazlauskas An In Vivo Gene Therapy Approach for Experimental Proliferative Vitreoretinopathy Using the Truncated Platelet-Derived Growth Factor {alpha} Receptor Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2406 - 2411. [Abstract] [Full Text] [PDF]

				Y. Ikuno, F.-L. Leong, and A. Kazlauskas PI3K and PLC{gamma} Play a Central Role in Experimental PVR Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 483 - 489. [Abstract] [Full Text] [PDF]

				Y. Ikuno and A. Kazlauskas TGF{beta}1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 41 - 46. [Abstract] [Full Text] [PDF]

				N. Wajih, J. Walter, and D. C. Sane Vascular Origin of a Soluble Truncated Form of the Hepatocyte Growth Factor Receptor (c-met) Circ. Res., January 11, 2002; 90(1): 46 - 52. [Abstract] [Full Text] [PDF]